447 related articles for article (PubMed ID: 26038816)
1. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.
Jamal A; Swarnalatha M; Sultana S; Joshi P; Panda SK; Kumar V
Cell Cycle; 2015; 14(16):2688-700. PubMed ID: 26038816
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus X protein enhances Myc stability by inhibiting SCF(Skp2) ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis.
Lee S; Kim W; Ko C; Ryu WS
Oncogene; 2016 Apr; 35(14):1857-67. PubMed ID: 26165841
[TBL] [Abstract][Full Text] [Related]
3. Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells.
Choi SH; Wright JB; Gerber SA; Cole MD
Genes Dev; 2010 Jun; 24(12):1236-41. PubMed ID: 20551172
[TBL] [Abstract][Full Text] [Related]
4. The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc.
Kalra N; Kumar V
FEBS Lett; 2006 Jan; 580(2):431-6. PubMed ID: 16376880
[TBL] [Abstract][Full Text] [Related]
5. Targeting the oncogenic E3 ligase Skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agent.
Wei S; Chu PC; Chuang HC; Hung WC; Kulp SK; Chen CS
PLoS One; 2012; 7(10):e47298. PubMed ID: 23071779
[TBL] [Abstract][Full Text] [Related]
6. E3 ligase SCF
Thacker G; Mishra M; Sharma A; Singh AK; Sanyal S; Trivedi AK
Life Sci; 2020 Sep; 257():118041. PubMed ID: 32622945
[TBL] [Abstract][Full Text] [Related]
7. Skp2 in the ubiquitin-proteasome system: A comprehensive review.
Asmamaw MD; Liu Y; Zheng YC; Shi XJ; Liu HM
Med Res Rev; 2020 Sep; 40(5):1920-1949. PubMed ID: 32391596
[TBL] [Abstract][Full Text] [Related]
8. Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.
Li B; Lu W; Yang Q; Yu X; Matusik RJ; Chen Z
Prostate; 2014 Apr; 74(4):421-32. PubMed ID: 24347472
[TBL] [Abstract][Full Text] [Related]
9. HBx regulates transcription factor PAX8 stabilization to promote the progression of hepatocellular carcinoma.
Wang J; Li N; Huang ZB; Fu S; Yu SM; Fu YM; Zhou PC; Chen RC; Zhou RR; Huang Y; Hu XW; Fan XG
Oncogene; 2019 Oct; 38(40):6696-6710. PubMed ID: 31391550
[TBL] [Abstract][Full Text] [Related]
10. p27(Kip1) signaling: Transcriptional and post-translational regulation.
Hnit SS; Xie C; Yao M; Holst J; Bensoussan A; De Souza P; Li Z; Dong Q
Int J Biochem Cell Biol; 2015 Nov; 68():9-14. PubMed ID: 26279144
[TBL] [Abstract][Full Text] [Related]
11. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells.
Bretones G; Acosta JC; Caraballo JM; Ferrándiz N; Gómez-Casares MT; Albajar M; Blanco R; Ruiz P; Hung WC; Albero MP; Perez-Roger I; León J
J Biol Chem; 2011 Mar; 286(11):9815-25. PubMed ID: 21245140
[TBL] [Abstract][Full Text] [Related]
12. Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells.
Chen JY; Wang MC; Hung WC
J Cell Physiol; 2011 Feb; 226(2):407-13. PubMed ID: 20717963
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21.
Huang Y; Tong S; Tai AW; Hussain M; Lok AS
Gastroenterology; 2011 Oct; 141(4):1412-21, 1421.e1-5. PubMed ID: 21704589
[TBL] [Abstract][Full Text] [Related]
14. DDB1 Stimulates Viral Transcription of Hepatitis B Virus via HBx-Independent Mechanisms.
Kim W; Lee S; Son Y; Ko C; Ryu WS
J Virol; 2016 Nov; 90(21):9644-9653. PubMed ID: 27535046
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin ligase TRUSS augments the expression of interleukin-10 via proteasomal processing of NF-κB1/p105 to NF-κB/p50.
Jamal A; Husein A; Bihari C; Kumar V
Cell Signal; 2020 Nov; 75():109766. PubMed ID: 32889079
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation.
Feng Z; Yin J; Zhang Z; Chen Z; Huang L; Tang N; Wang K
Oncogene; 2024 Apr; 43(15):1149-1159. PubMed ID: 38396292
[TBL] [Abstract][Full Text] [Related]
17. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription.
von der Lehr N; Johansson S; Wu S; Bahram F; Castell A; Cetinkaya C; Hydbring P; Weidung I; Nakayama K; Nakayama KI; Söderberg O; Kerppola TK; Larsson LG
Mol Cell; 2003 May; 11(5):1189-200. PubMed ID: 12769844
[TBL] [Abstract][Full Text] [Related]
18. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
[TBL] [Abstract][Full Text] [Related]
19. Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the G1-S transition.
Song MS; Song SJ; Kim SJ; Nakayama K; Nakayama KI; Lim DS
Oncogene; 2008 May; 27(22):3176-85. PubMed ID: 18071316
[TBL] [Abstract][Full Text] [Related]
20. Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition.
Gupta P; Zhao H; Hoang B; Schwartz EL
Br J Cancer; 2022 Oct; 127(6):969-975. PubMed ID: 35752713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]